Monthly Archives: February 2012

Rare Diseases Lead to Unique Legislation

Since 1983, pharma and patent organizations have been working together to influence policy aimed at improving the lives of those with rare diseases. In 1983—with the help of Abbey Meyers and the drive she had to help her son (more on that here)—the Orphan Drug Act was passed to incentivize pharma to step up and […]
Posted in Events, Global, Legal | Tagged , , , , , , | Leave a comment

Rare Disease Day: Spotlight on Solidarity

Patients, policymakers and pharmaceutical companies are uniting around rare diseases on the rarest of calendar days, presaging a leap forward in health outcomes and business opportunities. Aligning humanistic objectives with business incentives is often the sine qua non of effective community activism. This year’s Rare Disease Day – hosted in the US by the National […]
Posted in Events, FDA, Global, healthcare, leadership, Patient Communication, patient education, social media, Strategy | Tagged , , , , , , , | Leave a comment

Onyx Bullish in 2012 Outlook

With an all-important FDA decision on carfilzomib scheduled for July 27, Onyx hopes to graduate to the next stage of commercial success. For a feature-length profile of Onyx and CEO Tony Coles, click here. Following on a strong 4Q report, Onyx Pharmaceuticals’ CEO Tony Coles said the company hopes to transform itself from a one-product […]
Posted in FDA, Market Access, People, pricing, R&D, Regulatory, Strategy | Tagged , , , | Leave a comment

Combating Opioid Abuse With Science

So far, the creative approaches industry has taken to develop tamper-resistant and abuse-deterrent opioid drugs have been largely matched by the ingenuity of those users who manage to tamper with and abuse those same formulations.
Posted in FDA, R&D, Regulatory, Safety, Strategy, Technology | Tagged , , , | 3 Comments

Tasty Asian Acquisition for Publicis

Publicis Healthcare Gobbles Up Another Asian Agency Publicis continues its expansion into Asia with today’s (Feb 20) announcement of its acquisition of U-Link Business Solutions (UBS), one of China’s leading agencies specializing in healthcare communications. As a part of Publicis Healthcare Communications Group, the agency will be renamed UBS Saatchi & Saatchi Health. “The Chinese […]
Posted in Agency Insight, Emerging Markets, Global, Guest Blog | Tagged , , , , | Leave a comment
  • Categories

  • Meta